|Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations|
L Decoster, K Van Puyvelde, S Mohile, U Wedding, U Basso, G Colloca, ...
Annals of Oncology 26 (2), 288-300, 2015
|The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first …|
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox, GA Bjarnason, S Srinivas, ...
The lancet oncology 16 (3), 293-300, 2015
|Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019|
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
|Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer|
R Kanesvaran, H Li, KN Koo, D Poon
Journal of clinical oncology 29 (27), 3620-3627, 2011
|Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus|
G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ...
Annals of Oncology 31 (10), 1320-1335, 2020
|Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy|
AJ Templeton, JJ Knox, X Lin, R Simantov, W Xie, N Lawrence, R Broom, ...
European urology 70 (2), 358-364, 2016
|Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium|
CE Kyriakopoulos, N Chittoria, TK Choueiri, N Kroeger, JL Lee, S Srinivas, ...
Clinical genitourinary cancer 13 (2), e79-e85, 2015
|Third-line targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium|
JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee, F Donskov, ...
European urology 71 (2), 204-209, 2017
|Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer|
GGY Lai, TH Lim, J Lim, PJR Liew, XL Kwang, R Nahar, ZW Aung, ...
Journal of clinical oncology 37 (11), 876-884, 2019
|Comparison of preferences for end-of-life care among patients with advanced cancer and their caregivers: a discrete choice experiment|
C Malhotra, MA Farooqui, R Kanesvaran, M Bilger, E Finkelstein
Palliative medicine 29 (9), 842-850, 2015
|The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate|
MC Garassino, M Vyas, EGE De Vries, R Kanesvaran, R Giuliani, ...
Annals of Oncology 32 (5), 579-581, 2021
|Global geriatric oncology: achievements and challenges|
E Soto-Perez-de-Celis, NA de Glas, T Hsu, R Kanesvaran, C Steer, ...
Journal of Geriatric Oncology 8 (5), 374-386, 2017
|Checkpoint inhibitors in patients with metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium|
SM Yip, C Wells, R Moreira, A Wong, S Srinivas, B Beuselinck, C Porta, ...
Cancer 124 (18), 3677-3683, 2018
|Immunotherapy in older adults with advanced cancers: implications for clinical decision-making and future research|
R Kanesvaran, R Cordoba, R Maggiore
American Society of Clinical Oncology Educational Book 38, 400-414, 2018
|Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost …|
AC Tan, GGY Lai, G San Tan, SY Poon, B Doble, TH Lim, ZW Aung, ...
Lung Cancer 139, 207-215, 2020
|Adherence to oral cancer therapy in older adults: the International Society of Geriatric Oncology (SIOG) taskforce recommendations|
AR Mislang, TM Wildes, R Kanesvaran, C Baldini, HM Holmes, ...
Cancer treatment reviews 57, 58-66, 2017
|Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group|
NML Battisti, AR Mislang, L Cooper, A O'Donovan, RA Audisio, ...
Journal of geriatric oncology 11 (8), 1190-1198, 2020
|Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity|
Y Choudhury, YC Toh, J Xing, Y Qu, J Poh, H Li, HS Tan, R Kanesvaran, ...
Scientific reports 7 (1), 1-18, 2017
|Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma|
MH Tan, R Kanesvaran, H Li, HL Tan, PH Tan, CF Wong, KS Chia, ...
Urology 75 (6), 1365-1370. e3, 2010
|EGFR mutation subtypes influence survival outcomes following first-line gefitinib therapy in advanced Asian NSCLC patients|
N Sutiman, SW Tan, EH Tan, WT Lim, R Kanesvaran, QS Ng, A Jain, ...
Journal of Thoracic Oncology 12 (3), 529-538, 2017